Enrofloxacin
Sold as Baytril, Enrovet, Quinoex, Evanix, Afroxin, Enroxil flavour, Karifloxx
1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxoquinoline-3-carboxylic acid
Drag to rotate. Structure from PubChem CID 71188.
Background
Registration
- Applicants
- 5
- Registrations
- 15
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Elanco Animal Health (Pty) Ltd1 of 6 cancelled | Baytril | 5 %, 15 mg, 50 mg, 100, 150 mg | 02/06, 87/6, 88/10, 88/11, 88/12, 88/8 | S4 | None |
| Kyron Animal Health (Pty) Ltd | Enrovet, Evanix | 10 %, 100 mg/ml | 06/03, 10/15 | S4 | None |
| Ceva Animal Health (Pty) Ltd | Quinoex | 10 | 09/16 | S4 | None |
| Afrivet Business Management (Pty) Ltd | Afroxin | 50mg/ 100mg | 14/12, 14/13 | S4 | PI |
| Biotech Laboratories (Pty) Ltd | Enroxil flavour, Karifloxx | 15 mg, 50 mg, 100 mg, 150 mg | 21/02, 21/03, 21/04, 21/27 | S4 | PI |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Baytril 100 EACH 100,0 ml SOLUTION CONTAINS: ENROFLOXACIN 10,0 g | 100 | 02/0602/21.9/6 | Registered | S4 | None |
| Enrovet 10 % EACH 1,0 ml SOLUTION CONTAINS ENROFLOXACIN 100,0 mg | 10 % | 06/0306/21.9/03 | Registered | S4 | None |
| Quinoex 10 EACH 100,0 ml SOLUTION CONTAINS ENROFLOXACIN 10,0 g | 10 | 09/1609/17.1.6/16 | Registered | S4 | None |
| Evanix 100 mg/ml EACH 1,0 ml SOLUTION CONTAINS:ENROFLOXACIN 100,0 mg | 100 mg/ml | 10/1510/17.1.6/15 | Registered | S4 | None |
| Afroxin 5 % EACH 1,0 ml SOLUTION CONTAINS ENROFLOXACIN 50,0 mg | 50mg/ 100mgSolution for injection | 14/1214/17.1.6/12Approved 21 September 2021 | Registered | S4 | PI |
| Afroxin 10 % EACH 1,0 ml SOLUTION CONTAINS ENROFLOXACIN 100,0 mg | 50mg/ 100mgSolution for injection | 14/1314/17.1.6/13Approved 21 September 2021 | Registered | S4 | PI |
| Enroxil flavour15 MG Each tablet contains: Enrofloxacin 15 mg | 15 mg | 21/0221/17.1.6/02 | Registered | S4 | None |
| Enroxil flavour 50 MG Each Tablet contains: Enrofloxacin 50 mg | 50 mg | 21/0321/17.1.6/03 | Registered | S4 | None |
| Enroxil flavour 150 MG Each Tablet contains: Enrofloxacin 150 mg | 150 mg | 21/0421/17.1.6/04 | Registered | S4 | None |
| Karifloxx 100 mg/ml Each 1,0 ml Solution contains: Enrofloxacin 100,0 mg | 100 mgOral solution | 21/2721/17.1.6/27Approved 25 March 2025 | Registered | S4 | PI |
| Baytril EACH 1 ml SOLUTION CONTAINS ENROFLOXACIN 100 mg | Not listed | 87/687/21.9/6 | Cancelled | S4 | None |
| Baytril 15 MG tablets EACH TABLET CONTAINS ENROFLOXACIN 15 mg | 15 mgTablets | 88/1088/21.9/10 | Registered | S4 | None |
| Baytril 50 MG tablets EACH TABLET CONTAINS ENROFLOXACIN 50 mg | 50 mgTablets | 88/1188/21.9/11 | Registered | S4 | None |
| Baytril 150 MG tablets EACH TABLET CONTAINS ENROFLOXACIN 150 mg | 150 mgTablets | 88/1288/21.9/12 | Registered | S4 | None |
| Baytril 5 % EACH 1 ml SOLUTION CONTAINS ENROFLOXACIN 50 mg | 5 % | 88/888/21.9/8 | Registered | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Enrofloxacin
S4: Enrofloxacin
Consolidated Schedules 06 July 2026, line 6191
Pharmacological class: Androgen-oestrogen combinations. (class 21.9)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.